Travelbug2, I agreed with you. The ASX announcement is quite clear:
30 March 2020: PYC Therapeutics (ASX: PYC) (‘PYC’) will host an investor call for
shareholders on Wednesday 1 April 2020 at 9am AWST (11am AEST). The management
team of PYC will address questions on the efficacy read-outs in PYC’s lead drug
development program which will be announced to the Australian Securities Exchange
at 10am AEST on the same day.
More details would be announced at 10AM AEST on market open. That gives people 6 minutes to decide the open price. Then the Investor Call is at 11AM AEST. If it were bad news, there is no point to have an Investor Call session for the management to be grilled by share holders!
Travelbug2, I agreed with you. The ASX announcement is quite...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $466.6M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.8¢ | $519.2K | 5.169M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 182466 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 101115 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |